In the cases of breast cancer and cervical lesions, a higher expression level of TMEM45A has been correlated with a lower patient overall survival suggesting that TMEM45A is a potential biomarker for aggressiveness of breast cancer and cervical lesions (Flamant et al., 2012; Manawapat-Klopfer et al., 2016). This evidence concerns the gene TMEM45A and breast cancer.